Compile Data Set for Download or QSAR
Report error Found 706 Enz. Inhib. hit(s) with all data for entry = 88
TargetVoltage-dependent T-type calcium channel subunit alpha-1G(Human)
Degiacomo, Interim Trustee, Mark G.

US Patent
LigandPNGBDBM164208(US9688615, 19)
Affinity DataIC50: 4.5nMAssay Description:Cells were plated in 384-well, clear-bottom, black-walled, poly-D-lysine coated plates (Becton Dickinson, Franklin Lake, N.J.) 2 days prior to use in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/10/2018
Entry Details
Go to US Patent

TargetVoltage-dependent T-type calcium channel subunit alpha-1G(Human)
Degiacomo, Interim Trustee, Mark G.

US Patent
LigandPNGBDBM164209(US9688615, 20)
Affinity DataIC50: 20nMAssay Description:Cells were plated in 384-well, clear-bottom, black-walled, poly-D-lysine coated plates (Becton Dickinson, Franklin Lake, N.J.) 2 days prior to use in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/10/2018
Entry Details
Go to US Patent

TargetVoltage-dependent T-type calcium channel subunit alpha-1H(Human)
Degiacomo, Interim Trustee, Mark G.

US Patent
LigandPNGBDBM164209(US9688615, 20)
Affinity DataIC50: 30nMAssay Description:Cells were plated in 384-well, clear-bottom, black-walled, poly-D-lysine coated plates (Becton Dickinson, Franklin Lake, N.J.) 2 days prior to use in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/10/2018
Entry Details
Go to US Patent

TargetVoltage-dependent T-type calcium channel subunit alpha-1H(Human)
Degiacomo, Interim Trustee, Mark G.

US Patent
LigandPNGBDBM164208(US9688615, 19)
Affinity DataIC50: 40nMAssay Description:Cells were plated in 384-well, clear-bottom, black-walled, poly-D-lysine coated plates (Becton Dickinson, Franklin Lake, N.J.) 2 days prior to use in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/10/2018
Entry Details
Go to US Patent

TargetVoltage-dependent T-type calcium channel subunit alpha-1H(Human)
Degiacomo, Interim Trustee, Mark G.

US Patent
LigandPNGBDBM164209(US9688615, 20)
Affinity DataIC50: 50nMAssay Description:Cells were plated in 384-well, clear-bottom, black-walled, poly-D-lysine coated plates (Becton Dickinson, Franklin Lake, N.J.) 2 days prior to use in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/10/2018
Entry Details
Go to US Patent

TargetVoltage-dependent T-type calcium channel subunit alpha-1G(Human)
Degiacomo, Interim Trustee, Mark G.

US Patent
LigandPNGBDBM163526(US9688615, 1)
Affinity DataIC50: 60nMAssay Description:Cells were plated in 384-well, clear-bottom, black-walled, poly-D-lysine coated plates (Becton Dickinson, Franklin Lake, N.J.) 2 days prior to use in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/10/2018
Entry Details
Go to US Patent

TargetVoltage-dependent T-type calcium channel subunit alpha-1H(Human)
Degiacomo, Interim Trustee, Mark G.

US Patent
LigandPNGBDBM164199(US9688615, 10)
Affinity DataIC50: 80nMAssay Description:Cells were plated in 384-well, clear-bottom, black-walled, poly-D-lysine coated plates (Becton Dickinson, Franklin Lake, N.J.) 2 days prior to use in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/10/2018
Entry Details
Go to US Patent

TargetVoltage-dependent T-type calcium channel subunit alpha-1G(Human)
Degiacomo, Interim Trustee, Mark G.

US Patent
LigandPNGBDBM164199(US9688615, 10)
Affinity DataIC50: 150nMAssay Description:Cells were plated in 384-well, clear-bottom, black-walled, poly-D-lysine coated plates (Becton Dickinson, Franklin Lake, N.J.) 2 days prior to use in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/10/2018
Entry Details
Go to US Patent

TargetVoltage-dependent T-type calcium channel subunit alpha-1H(Human)
Degiacomo, Interim Trustee, Mark G.

US Patent
LigandPNGBDBM164199(US9688615, 10)
Affinity DataIC50: 280nMAssay Description:Cells were plated in 384-well, clear-bottom, black-walled, poly-D-lysine coated plates (Becton Dickinson, Franklin Lake, N.J.) 2 days prior to use in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/10/2018
Entry Details
Go to US Patent

TargetVoltage-dependent T-type calcium channel subunit alpha-1H(Human)
Degiacomo, Interim Trustee, Mark G.

US Patent
LigandPNGBDBM164221(US9688615, 32)
Affinity DataIC50: 290nMAssay Description:Cells were plated in 384-well, clear-bottom, black-walled, poly-D-lysine coated plates (Becton Dickinson, Franklin Lake, N.J.) 2 days prior to use in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/10/2018
Entry Details
Go to US Patent

TargetVoltage-dependent T-type calcium channel subunit alpha-1H(Human)
Degiacomo, Interim Trustee, Mark G.

US Patent
LigandPNGBDBM164208(US9688615, 19)
Affinity DataIC50: 530nMAssay Description:Cells were plated in 384-well, clear-bottom, black-walled, poly-D-lysine coated plates (Becton Dickinson, Franklin Lake, N.J.) 2 days prior to use in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/10/2018
Entry Details
Go to US Patent

TargetVoltage-dependent T-type calcium channel subunit alpha-1H(Human)
Degiacomo, Interim Trustee, Mark G.

US Patent
LigandPNGBDBM164324(US9688615, 135)
Affinity DataIC50: 640nMAssay Description:Cells were plated in 384-well, clear-bottom, black-walled, poly-D-lysine coated plates (Becton Dickinson, Franklin Lake, N.J.) 2 days prior to use in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/10/2018
Entry Details
Go to US Patent

TargetVoltage-dependent T-type calcium channel subunit alpha-1H(Human)
Degiacomo, Interim Trustee, Mark G.

US Patent
LigandPNGBDBM163549(US9688615, 3)
Affinity DataIC50: 670nMAssay Description:Cells were plated in 384-well, clear-bottom, black-walled, poly-D-lysine coated plates (Becton Dickinson, Franklin Lake, N.J.) 2 days prior to use in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/10/2018
Entry Details
Go to US Patent

TargetVoltage-dependent T-type calcium channel subunit alpha-1H(Human)
Degiacomo, Interim Trustee, Mark G.

US Patent
LigandPNGBDBM164228(US9688615, 39)
Affinity DataIC50: 680nMAssay Description:Cells were plated in 384-well, clear-bottom, black-walled, poly-D-lysine coated plates (Becton Dickinson, Franklin Lake, N.J.) 2 days prior to use in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/10/2018
Entry Details
Go to US Patent

TargetVoltage-dependent T-type calcium channel subunit alpha-1G(Human)
Degiacomo, Interim Trustee, Mark G.

US Patent
LigandPNGBDBM164262(US9688615, 73)
Affinity DataIC50: 890nMAssay Description:Cells were plated in 384-well, clear-bottom, black-walled, poly-D-lysine coated plates (Becton Dickinson, Franklin Lake, N.J.) 2 days prior to use in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/10/2018
Entry Details
Go to US Patent

TargetVoltage-dependent T-type calcium channel subunit alpha-1G(Human)
Degiacomo, Interim Trustee, Mark G.

US Patent
LigandPNGBDBM163549(US9688615, 3)
Affinity DataIC50: 900nMAssay Description:Cells were plated in 384-well, clear-bottom, black-walled, poly-D-lysine coated plates (Becton Dickinson, Franklin Lake, N.J.) 2 days prior to use in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/10/2018
Entry Details
Go to US Patent

TargetVoltage-dependent T-type calcium channel subunit alpha-1H(Human)
Degiacomo, Interim Trustee, Mark G.

US Patent
LigandPNGBDBM164361(US9688615, 172)
Affinity DataIC50: 1.00E+3nMAssay Description:Cells were plated in 384-well, clear-bottom, black-walled, poly-D-lysine coated plates (Becton Dickinson, Franklin Lake, N.J.) 2 days prior to use in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/10/2018
Entry Details
Go to US Patent

TargetVoltage-dependent N-type calcium channel subunit alpha-1B(Human)
Degiacomo, Interim Trustee, Mark G.

US Patent
LigandPNGBDBM164209(US9688615, 20)
Affinity DataIC50: 1.13E+3nMAssay Description:Cells were plated in 384-well, clear-bottom, black-walled, poly-D-lysine coated plates (Becton Dickinson, Franklin Lake, N.J.) 2 days prior to use in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/10/2018
Entry Details
Go to US Patent

TargetVoltage-dependent T-type calcium channel subunit alpha-1H(Human)
Degiacomo, Interim Trustee, Mark G.

US Patent
LigandPNGBDBM164262(US9688615, 73)
Affinity DataIC50: 1.20E+3nMAssay Description:Cells were plated in 384-well, clear-bottom, black-walled, poly-D-lysine coated plates (Becton Dickinson, Franklin Lake, N.J.) 2 days prior to use in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/10/2018
Entry Details
Go to US Patent

TargetVoltage-dependent T-type calcium channel subunit alpha-1H(Human)
Degiacomo, Interim Trustee, Mark G.

US Patent
LigandPNGBDBM164262(US9688615, 73)
Affinity DataIC50: 1.20E+3nMAssay Description:Cells were plated in 384-well, clear-bottom, black-walled, poly-D-lysine coated plates (Becton Dickinson, Franklin Lake, N.J.) 2 days prior to use in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/10/2018
Entry Details
Go to US Patent

TargetVoltage-dependent T-type calcium channel subunit alpha-1H(Human)
Degiacomo, Interim Trustee, Mark G.

US Patent
LigandPNGBDBM164220(US9688615, 31)
Affinity DataIC50: 1.26E+3nMAssay Description:Cells were plated in 384-well, clear-bottom, black-walled, poly-D-lysine coated plates (Becton Dickinson, Franklin Lake, N.J.) 2 days prior to use in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/10/2018
Entry Details
Go to US Patent

TargetVoltage-dependent T-type calcium channel subunit alpha-1H(Human)
Degiacomo, Interim Trustee, Mark G.

US Patent
LigandPNGBDBM164360(US9688615, 171)
Affinity DataIC50: 1.31E+3nMAssay Description:Cells were plated in 384-well, clear-bottom, black-walled, poly-D-lysine coated plates (Becton Dickinson, Franklin Lake, N.J.) 2 days prior to use in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/10/2018
Entry Details
Go to US Patent

TargetVoltage-dependent T-type calcium channel subunit alpha-1H(Human)
Degiacomo, Interim Trustee, Mark G.

US Patent
LigandPNGBDBM164363(US9688615, 174)
Affinity DataIC50: 1.50E+3nMAssay Description:Cells were plated in 384-well, clear-bottom, black-walled, poly-D-lysine coated plates (Becton Dickinson, Franklin Lake, N.J.) 2 days prior to use in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/10/2018
Entry Details
Go to US Patent

TargetVoltage-dependent T-type calcium channel subunit alpha-1H(Human)
Degiacomo, Interim Trustee, Mark G.

US Patent
LigandPNGBDBM164203(US9688615, 14)
Affinity DataIC50: 1.76E+3nMAssay Description:Cells were plated in 384-well, clear-bottom, black-walled, poly-D-lysine coated plates (Becton Dickinson, Franklin Lake, N.J.) 2 days prior to use in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/10/2018
Entry Details
Go to US Patent

TargetVoltage-dependent T-type calcium channel subunit alpha-1H(Human)
Degiacomo, Interim Trustee, Mark G.

US Patent
LigandPNGBDBM163549(US9688615, 3)
Affinity DataIC50: 1.85E+3nMAssay Description:Cells were plated in 384-well, clear-bottom, black-walled, poly-D-lysine coated plates (Becton Dickinson, Franklin Lake, N.J.) 2 days prior to use in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/10/2018
Entry Details
Go to US Patent

TargetVoltage-dependent T-type calcium channel subunit alpha-1H(Human)
Degiacomo, Interim Trustee, Mark G.

US Patent
LigandPNGBDBM164364(US9688615, 175)
Affinity DataIC50: 1.90E+3nMAssay Description:Cells were plated in 384-well, clear-bottom, black-walled, poly-D-lysine coated plates (Becton Dickinson, Franklin Lake, N.J.) 2 days prior to use in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/10/2018
Entry Details
Go to US Patent

TargetVoltage-dependent T-type calcium channel subunit alpha-1G(Human)
Degiacomo, Interim Trustee, Mark G.

US Patent
LigandPNGBDBM163533(US9688615, 2)
Affinity DataIC50: 1.98E+3nMAssay Description:Cells were plated in 384-well, clear-bottom, black-walled, poly-D-lysine coated plates (Becton Dickinson, Franklin Lake, N.J.) 2 days prior to use in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/10/2018
Entry Details
Go to US Patent

TargetVoltage-dependent T-type calcium channel subunit alpha-1H(Human)
Degiacomo, Interim Trustee, Mark G.

US Patent
LigandPNGBDBM163526(US9688615, 1)
Affinity DataIC50: 1.98E+3nMAssay Description:Cells were plated in 384-well, clear-bottom, black-walled, poly-D-lysine coated plates (Becton Dickinson, Franklin Lake, N.J.) 2 days prior to use in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/10/2018
Entry Details
Go to US Patent

TargetVoltage-dependent T-type calcium channel subunit alpha-1H(Human)
Degiacomo, Interim Trustee, Mark G.

US Patent
LigandPNGBDBM164362(US9688615, 173)
Affinity DataIC50: 2.10E+3nMAssay Description:Cells were plated in 384-well, clear-bottom, black-walled, poly-D-lysine coated plates (Becton Dickinson, Franklin Lake, N.J.) 2 days prior to use in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/10/2018
Entry Details
Go to US Patent

TargetVoltage-dependent T-type calcium channel subunit alpha-1H(Human)
Degiacomo, Interim Trustee, Mark G.

US Patent
LigandPNGBDBM164252(US9688615, 63)
Affinity DataIC50: 2.20E+3nMAssay Description:Cells were plated in 384-well, clear-bottom, black-walled, poly-D-lysine coated plates (Becton Dickinson, Franklin Lake, N.J.) 2 days prior to use in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/10/2018
Entry Details
Go to US Patent

TargetVoltage-dependent T-type calcium channel subunit alpha-1H(Human)
Degiacomo, Interim Trustee, Mark G.

US Patent
LigandPNGBDBM163533(US9688615, 2)
Affinity DataIC50: 2.23E+3nMAssay Description:Cells were plated in 384-well, clear-bottom, black-walled, poly-D-lysine coated plates (Becton Dickinson, Franklin Lake, N.J.) 2 days prior to use in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/10/2018
Entry Details
Go to US Patent

TargetVoltage-dependent T-type calcium channel subunit alpha-1H(Human)
Degiacomo, Interim Trustee, Mark G.

US Patent
LigandPNGBDBM164331(US9688615, 142)
Affinity DataIC50: 2.25E+3nMAssay Description:Cells were plated in 384-well, clear-bottom, black-walled, poly-D-lysine coated plates (Becton Dickinson, Franklin Lake, N.J.) 2 days prior to use in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/10/2018
Entry Details
Go to US Patent

TargetVoltage-dependent T-type calcium channel subunit alpha-1G(Human)
Degiacomo, Interim Trustee, Mark G.

US Patent
LigandPNGBDBM164223(US9688615, 34)
Affinity DataIC50: 2.35E+3nMAssay Description:Cells were plated in 384-well, clear-bottom, black-walled, poly-D-lysine coated plates (Becton Dickinson, Franklin Lake, N.J.) 2 days prior to use in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/10/2018
Entry Details
Go to US Patent

TargetVoltage-dependent T-type calcium channel subunit alpha-1H(Human)
Degiacomo, Interim Trustee, Mark G.

US Patent
LigandPNGBDBM164200(US9688615, 11)
Affinity DataIC50: 2.40E+3nMAssay Description:Cells were plated in 384-well, clear-bottom, black-walled, poly-D-lysine coated plates (Becton Dickinson, Franklin Lake, N.J.) 2 days prior to use in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/10/2018
Entry Details
Go to US Patent

TargetVoltage-dependent T-type calcium channel subunit alpha-1H(Human)
Degiacomo, Interim Trustee, Mark G.

US Patent
LigandPNGBDBM164261(US9688615, 72)
Affinity DataIC50: 2.40E+3nMAssay Description:Cells were plated in 384-well, clear-bottom, black-walled, poly-D-lysine coated plates (Becton Dickinson, Franklin Lake, N.J.) 2 days prior to use in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/10/2018
Entry Details
Go to US Patent

TargetVoltage-dependent L-type calcium channel subunit alpha-1C(Human)
Degiacomo, Interim Trustee, Mark G.

US Patent
LigandPNGBDBM164209(US9688615, 20)
Affinity DataIC50: 2.58E+3nMpH: 7.4Assay Description:To assess the potential cardiac liability of compounds at an early stage in the drug discovery process, a Nav1.5 sodium channel screening assay was b...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/10/2018
Entry Details
Go to US Patent

TargetVoltage-dependent N-type calcium channel subunit alpha-1B(Human)
Degiacomo, Interim Trustee, Mark G.

US Patent
LigandPNGBDBM164208(US9688615, 19)
Affinity DataIC50: 2.94E+3nMAssay Description:Cells were plated in 384-well, clear-bottom, black-walled, poly-D-lysine coated plates (Becton Dickinson, Franklin Lake, N.J.) 2 days prior to use in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/10/2018
Entry Details
Go to US Patent

TargetVoltage-dependent L-type calcium channel subunit alpha-1C(Human)
Degiacomo, Interim Trustee, Mark G.

US Patent
LigandPNGBDBM164220(US9688615, 31)
Affinity DataIC50: 2.99E+3nMpH: 7.4Assay Description:To assess the potential cardiac liability of compounds at an early stage in the drug discovery process, a Nav1.5 sodium channel screening assay was b...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/10/2018
Entry Details
Go to US Patent

TargetVoltage-dependent T-type calcium channel subunit alpha-1G(Human)
Degiacomo, Interim Trustee, Mark G.

US Patent
LigandPNGBDBM164360(US9688615, 171)
Affinity DataIC50: 3.08E+3nMAssay Description:Cells were plated in 384-well, clear-bottom, black-walled, poly-D-lysine coated plates (Becton Dickinson, Franklin Lake, N.J.) 2 days prior to use in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/10/2018
Entry Details
Go to US Patent

TargetVoltage-dependent T-type calcium channel subunit alpha-1H(Human)
Degiacomo, Interim Trustee, Mark G.

US Patent
LigandPNGBDBM164213(US9688615, 24)
Affinity DataIC50: 3.09E+3nMAssay Description:Cells were plated in 384-well, clear-bottom, black-walled, poly-D-lysine coated plates (Becton Dickinson, Franklin Lake, N.J.) 2 days prior to use in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/10/2018
Entry Details
Go to US Patent

TargetVoltage-dependent T-type calcium channel subunit alpha-1G(Human)
Degiacomo, Interim Trustee, Mark G.

US Patent
LigandPNGBDBM164363(US9688615, 174)
Affinity DataIC50: 3.40E+3nMAssay Description:Cells were plated in 384-well, clear-bottom, black-walled, poly-D-lysine coated plates (Becton Dickinson, Franklin Lake, N.J.) 2 days prior to use in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/10/2018
Entry Details
Go to US Patent

TargetVoltage-dependent T-type calcium channel subunit alpha-1H(Human)
Degiacomo, Interim Trustee, Mark G.

US Patent
LigandPNGBDBM164231(US9688615, 42)
Affinity DataIC50: 3.43E+3nMAssay Description:Cells were plated in 384-well, clear-bottom, black-walled, poly-D-lysine coated plates (Becton Dickinson, Franklin Lake, N.J.) 2 days prior to use in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/10/2018
Entry Details
Go to US Patent

TargetVoltage-dependent L-type calcium channel subunit alpha-1C(Human)
Degiacomo, Interim Trustee, Mark G.

US Patent
LigandPNGBDBM164208(US9688615, 19)
Affinity DataIC50: 3.56E+3nMpH: 7.4Assay Description:To assess the potential cardiac liability of compounds at an early stage in the drug discovery process, a Nav1.5 sodium channel screening assay was b...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/10/2018
Entry Details
Go to US Patent

TargetSodium channel protein type 5 subunit alpha(Human)
Degiacomo, Interim Trustee, Mark G.

US Patent
LigandPNGBDBM164223(US9688615, 34)
Affinity DataIC50: 3.60E+3nMpH: 7.4Assay Description:To assess the potential cardiac liability of compounds at an early stage in the drug discovery process, a Nav1.5 sodium channel screening assay was b...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/10/2018
Entry Details
Go to US Patent

TargetVoltage-dependent T-type calcium channel subunit alpha-1H(Human)
Degiacomo, Interim Trustee, Mark G.

US Patent
LigandPNGBDBM164227(US9688615, 38)
Affinity DataIC50: 3.80E+3nMAssay Description:Cells were plated in 384-well, clear-bottom, black-walled, poly-D-lysine coated plates (Becton Dickinson, Franklin Lake, N.J.) 2 days prior to use in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/10/2018
Entry Details
Go to US Patent

TargetVoltage-dependent T-type calcium channel subunit alpha-1H(Human)
Degiacomo, Interim Trustee, Mark G.

US Patent
LigandPNGBDBM164237(US9688615, 48)
Affinity DataIC50: 3.80E+3nMAssay Description:Cells were plated in 384-well, clear-bottom, black-walled, poly-D-lysine coated plates (Becton Dickinson, Franklin Lake, N.J.) 2 days prior to use in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/10/2018
Entry Details
Go to US Patent

TargetVoltage-dependent N-type calcium channel subunit alpha-1B(Human)
Degiacomo, Interim Trustee, Mark G.

US Patent
LigandPNGBDBM164250(US9688615, 61)
Affinity DataIC50: 3.90E+3nMAssay Description:Cells were plated in 384-well, clear-bottom, black-walled, poly-D-lysine coated plates (Becton Dickinson, Franklin Lake, N.J.) 2 days prior to use in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/10/2018
Entry Details
Go to US Patent

TargetVoltage-dependent L-type calcium channel subunit alpha-1C(Human)
Degiacomo, Interim Trustee, Mark G.

US Patent
LigandPNGBDBM164209(US9688615, 20)
Affinity DataIC50: 3.90E+3nMpH: 7.4Assay Description:To assess the potential cardiac liability of compounds at an early stage in the drug discovery process, a Nav1.5 sodium channel screening assay was b...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/10/2018
Entry Details
Go to US Patent

TargetVoltage-dependent N-type calcium channel subunit alpha-1B(Human)
Degiacomo, Interim Trustee, Mark G.

US Patent
LigandPNGBDBM164237(US9688615, 48)
Affinity DataIC50: 4.00E+3nMAssay Description:Cells were plated in 384-well, clear-bottom, black-walled, poly-D-lysine coated plates (Becton Dickinson, Franklin Lake, N.J.) 2 days prior to use in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/10/2018
Entry Details
Go to US Patent

TargetVoltage-dependent N-type calcium channel subunit alpha-1B(Human)
Degiacomo, Interim Trustee, Mark G.

US Patent
LigandPNGBDBM164229(US9688615, 40)
Affinity DataIC50: 4.05E+3nMAssay Description:Cells were plated in 384-well, clear-bottom, black-walled, poly-D-lysine coated plates (Becton Dickinson, Franklin Lake, N.J.) 2 days prior to use in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/10/2018
Entry Details
Go to US Patent

Displayed 1 to 50 (of 706 total ) | Next | Last >>
Jump to: